Oregon Health and Science University, Portland, USA.
Health Aff (Millwood). 2013 Mar;32(3):603-13. doi: 10.1377/hlthaff.2012.0945. Epub 2013 Feb 13.
In response to increasing abuse of prescription drugs, forty-four states have implemented--and five more states will soon adopt--monitoring programs to track prescriptions of controlled medications. Although these programs were originally designed to help law enforcement officials and regulatory agencies spot possible illegal activity, health care providers have begun to use data from them to help improve patient safety and quality of care. For this article we reviewed government documents, expert white papers, articles from the peer-reviewed medical literature, and reports of the experiences of local health officials. We found some evidence that prescription drug monitoring programs are a benefit to both law enforcement and health care delivery. However, the programs have strengths and weaknesses, and their overall impact on drug abuse and illegal activity remains unclear. We believe that improving the efficacy of prescription drug monitoring programs will require such changes as more standardization and interstate cooperation, better training of providers, more secure funding, and further evaluation.
为应对处方药滥用问题日益严重的状况，有 44 个州已经实施了——另外还有 5 个州即将采用——监控项目，以追踪管制药物的处方情况。虽然这些项目最初是为了帮助执法官员和监管机构发现可能的非法活动而设计的，但医疗保健提供者已开始利用这些项目的数据来帮助提高患者的安全性和护理质量。在本文中，我们审查了政府文件、专家白皮书、同行评议的医学文献中的文章以及地方卫生官员经验的报告。我们发现了一些证据表明，处方药物监测项目对执法和医疗服务提供都有益处。然而，这些项目有其优势和劣势，其对药物滥用和非法活动的总体影响仍不清楚。我们认为，提高处方药物监测项目的效果需要进行一些变革，如加强标准化和州际合作、更好地培训提供者、更安全的资金支持以及进一步评估。
